Page last updated: 2024-10-23

bendroflumethiazide and Rhabdomyolysis

bendroflumethiazide has been researched along with Rhabdomyolysis in 1 studies

Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.

Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.

Research Excerpts

ExcerptRelevanceReference
"Rhabdomyolysis is a severe condition with an incidence of 28% in hypokalaemic patients."1.40[Rhabdomyolysis caused by thiazid-induced hypokalaemia]. ( Bach, PT; Raaber, N, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bach, PT1
Raaber, N1

Other Studies

1 other study available for bendroflumethiazide and Rhabdomyolysis

ArticleYear
[Rhabdomyolysis caused by thiazid-induced hypokalaemia].
    Ugeskrift for laeger, 2014, Sep-15, Volume: 176, Issue:38

    Topics: Adult; Bendroflumethiazide; Female; Humans; Hypokalemia; Rhabdomyolysis; Thiazides

2014